I. Lucki

B. Pollock, I. Lucki, T. Ten Have, 2001, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

The effect of anxiolytic drugs on memory in anxious subjects.

I. Lucki, K. Rickels, 1988, Psychopharmacology series.

Differential effects of the anxiolytic drugs, diazepam and buspirone, on memory function.

I. Lucki, K. Rickels, A. Geller, 1987, British journal of clinical pharmacology.

Choice responding following multiple schedule training

I. Lucki, E. L. Edmon, M. Grisham, 1980 .

Resistance to the anti-anxiety effect of buspirone in patients with a history of benzodiazepine use.

I. Lucki, K. Rickels, E. Schweizer, 1986, The New England journal of medicine.

The effects of different stressors on extracellular 5-hydroxytryptamine and 5-hydroxyindoleacetic acid

I. Lucki, L. Kirby, Jennifer M. Chou-Green, 1997, Brain Research.

Corticotropin-releasing Factor in the Rat Dorsal Raphe Nucleus Promotes Different Forms of Behavioral Flexibility Depending on Social Stress History

I. Lucki, R. Valentino, T. Hill-Smith, 2015, Neuropsychopharmacology.

Novel Targets to Treat Depression: Opioid-Based Therapeutics.

I. Lucki, Moriah L. Jacobson, C. Browne, 2020, Harvard review of psychiatry.

Opioid modulation of cognitive impairment in depression.

I. Lucki, Moriah L. Jacobson, C. Browne, 2018, Progress in brain research.

VMAT1 deletion causes neuronal loss in the hippocampus and neurocognitive deficits in spatial discrimination

I. Lucki, T. Abel, H. Kung, 2013, Neuroscience.

Differential regulation of the behavioral effects of chlordiazepoxide

I. Lucki, J. Shumsky, 1994, Psychopharmacology.

Differential tolerance to the effects of chlordiazepoxide on unpunished and punished operant responding following chronic treatment

I. Lucki, J. Shumsky, 1996, Pharmacology, Biochemistry and Behavior.

Fluoxetine treatment induces dose dependent alterations in depression associated behavior and neural plasticity in female mice

I. Lucki, G. Hodes, T. Hill-Smith, 2010, Neuroscience Letters.

Removal of high-fat diet after chronic exposure drives binge behavior and dopaminergic dysregulation in female mice

I. Lucki, T. Reyes, N. Grissom, 2016, Neuroscience.

Noradrenergic lesions differentially alter the antidepressant-like effects of reboxetine in a modified forced swim test.

I. Lucki, J. Cryan, M. Page, 2002, European journal of pharmacology.

Increased sensitivity to benzodiazepine antagonists in rats following chronic treatment with a low dose of diazepam

I. Lucki, R. Kucharik, 2005, Psychopharmacology.

Rate-dependent effects of amphetamine on responding under random-interval schedules of reinforcement in the rat

I. Lucki, 1983, Pharmacology Biochemistry and Behavior.

Serotonergic involvement in haloperidol-induced catalepsy.

I. Lucki, J. Joyce, B. Neal-Beliveau, 1993, The Journal of pharmacology and experimental therapeutics.

Antidepressant and anxiolytic effects of selective 5-HT6 receptor agonists in rats

I. Lucki, L. Schechter, Gregory V. Carr, 2011, Psychopharmacology.

The long-term effects of diazepam and pentylenetetrazol on behavioral sensitivity to a stressor

I. Lucki, T. Davidson, 1987, Pharmacology Biochemistry and Behavior.

Distinguishing roles for norepinephrine and serotonin in the behavioral effects of antidepressant drugs.

I. Lucki, O. O'Leary, 2004, The Journal of clinical psychiatry.

Amplified behavioral and endocrine responses to forced swim stress in the Wistar–Kyoto rat

I. Lucki, G. Stanwood, C. López-Rubalcava, 2002, Psychoneuroendocrinology.

The effect of repeated exposure to forced swimming on extracellular levels of 5-hydroxytryptamine in the rat.

I. Lucki, L. Kirby, 1998, Stress.

The kappa opioid receptor antagonist aticaprant reverses behavioral effects from unpredictable chronic mild stress in male mice

I. Lucki, Moriah L. Jacobson, C. Browne, 2020, Psychopharmacology.

Limitations on the use of the C57BL/6 mouse in the tail suspension test

I. Lucki, A. J. Mayorga, 2001, Psychopharmacology.

Antidepressant behavioral effects by dual inhibition of monoamine reuptake in the rat forced swimming test

I. Lucki, J. Reneric, 1998, Psychopharmacology.

Serotonergic properties of cocaine: Effects on a 5-HT2 receptor-mediated behavior and on extracellular concentrations of serotonin and dopamine

I. Lucki, W. Essman, A. Singh, 1994, Pharmacology Biochemistry and Behavior.

Antidepressant-like effects of buprenorphine in rats are strain dependent

I. Lucki, C. Browne, D. V. Nest, 2015, Behavioural Brain Research.

A role for corticotropin-releasing factor signaling in the lateral habenula and its modulation by early-life stress

I. Lucki, H. Kassis, Fereshteh S. Nugent, 2018, Science Signaling.

The 5-HT1A Receptor Antagonist p-MPPI Blocks Responses Mediated by Postsynaptic and Presynaptic 5-HT1A Receptors

I. Lucki, H. Kung, M. Kung, 1997, Pharmacology Biochemistry and Behavior.

Effect of chronic treatments with tandospirone and imipramine on serotonin-mediated behavioral responses and monoamine receptors

I. Lucki, S. Wieland, C. Fischette, 1993, Neuropharmacology.

Altered behavioral responses mediated by serotonin receptors in the genetically dystonic (dt) rat

I. Lucki, S. Wieland, 1991, Brain Research Bulletin.

Destruction of the nucleus raphe obscurus and potentiation of serotonin-mediated behaviors following administration of the neurotoxin 3-acetylpyridine

I. Lucki, P. Mcgonigle, S. Wieland, 1990, Brain Research.

Blockade of the antidepressant-like effects of 8-OH-DPAT, buspirone and desipramine in the rat forced swim test by 5HT1A receptor antagonists

M. Detke, I. Lucki, S. Wieland, 1995, Psychopharmacology.

Differential regulation of serotonin (5-HT) release in the striatum and hippocampus by 5-HT1A autoreceptors of the dorsal and median raphe nuclei.

I. Lucki, D. S. Kreiss, 1994, The Journal of pharmacology and experimental therapeutics.

Dopaminergic Stimulation of Subthalamic Nucleus Elicits Oral Dyskinesia in Rats

I. Lucki, M. Chesselet, T. Parry, 1994, Experimental Neurology.

Discriminative stimulus properties of the benzodiazepine receptor inverse agonist methyl-6,7-dimethoxy-4-ethyl-β-carboline-3-carboxylate (DMCM)

G. A. Rowan, I. Lucki, L. Kirby, 2005, Psychopharmacology.

Simultaneous analyses of the neurochemical and behavioral effects of the norepinephrine reuptake inhibitor reboxetine in a rat model of antidepressant action

I. Lucki, M. Page, K. Brown, 2002, Psychopharmacology.

Differential blockade of CRF-evoked behaviors by depletion of norepinephrine and serotonin in rats

I. Lucki, R. Valentino, Gregory V. Carr, 2008, Psychopharmacology.

Flow cytometric analysis of BrdU incorporation as a high-throughput method for measuring adult neurogenesis in the mouse.

I. Lucki, J. Dwyer, D. Balu, 2009, Journal of pharmacological and toxicological methods.

Comparison of the effects of zaleplon, zolpidem, and triazolam on memory, learning, and psychomotor performance.

I. Lucki, P. Furlan, S. Troy, 2000, Journal of clinical psychopharmacology.

Regional patterns of compensation following genetic deletion of either 5-hydroxytryptamine(1A) or 5-hydroxytryptamine(1B) receptor in the mouse.

I. Lucki, R. Hen, J. Blendy, 2001, The Journal of pharmacology and experimental therapeutics.

Genetic regulation of extracellular serotonin by 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) autoreceptors in different brain regions of the mouse.

I. Lucki, R. Hen, René Hen, 2001, The Journal of pharmacology and experimental therapeutics.

Desensitization of 5-HT1A autoreceptors by chronic administration of 8-OH-DPAT

I. Lucki, D. S. Kreiss, 1992, Neuropharmacology.

Chronic corticosterone exposure alters postsynaptic protein levels of PSD‐95, NR1, and synaptopodin in the mouse brain

D. Bennett, I. Lucki, S. Arnold, 2011, Synapse.

Strain-dependent antidepressant-like effects of citalopram in the mouse tail suspension test

I. Lucki, J. Crowley, J. Blendy, 2005, Psychopharmacology.

Serotonin revisited

P. Cowen, I. Lucki, 2010, Psychopharmacology.

Behavioral analysis of CREB alphadelta mutation on a B6/129 F1 hybrid background.

I. Lucki, T. Abel, J. Blendy, 2002, Hippocampus.

Continuous light paradoxically reduces catecholamine-induced melatonin production

I. Lucki, A. Frazer, W. Heydorn, 1983, Brain Research.

The presence of a serotonin uptake inhibitor alters pharmacological manipulations of serotonin release

I. Lucki, S. Wieland, D. S. Kreiss, 1993, Neuroscience.

Antidepressant-like activity of 5-HT1A agonists measured with the forced swim test

I. Lucki, S. Wieland, 2005, Psychopharmacology.

Antidepressant-like activity of compounds with varying efficacy at 5-HT1A receptors

I. Lucki, Ashish Singh, 1993, Neuropharmacology.

Sex-Specific Effects of Chronic Fluoxetine Treatment on Neuroplasticity and Pharmacokinetics in Mice

I. Lucki, T. Cooper, R. Suckow, 2010, Journal of Pharmacology and Experimental Therapeutics.

Long-term effects of yohimbine on behavioral sensitivity to a stressor

I. Lucki, T. Davidson, 2004, Psychopharmacology.

Effects of Corticotropin-Releasing Factor on Brain Serotonergic Activity

I. Lucki, R. Valentino, L. Kirby, 1998, Neuropsychopharmacology.

Regional differences in the effects of forced swimming on extracellular levels of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid

I. Lucki, L. Kirby, A. Allen, 1995, Brain Research.

Changes in behavioral sensitivity to SKF-38393 and quinpirole following withdrawal from continuous cocaine administration in rats

I. Lucki, P. Mcgonigle, J. Neisewander, 1996, Pharmacology Biochemistry and Behavior.

Regulation of extracellular concentrations of 5-hydroxytryptamine (5-HT) in mouse striatum by 5-HT(1A) and 5-HT(1B) receptors.

I. Lucki, H. Kung, D. A. Knobelman, 2000, The Journal of pharmacology and experimental therapeutics.

Behavioral and Neurochemical Effects of 5-{4-[4-(5-Cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl}-benzofuran-2-carboxamide (EMD 68843): A Combined Selective Inhibitor of Serotonin Reuptake and 5-Hydroxytryptamine1A Receptor Partial Agonist

I. Lucki, J. Cryan, M. Page, 2002, Journal of Pharmacology and Experimental Therapeutics.

Reduction of feeding behavior by the serotonin uptake inhibitor sertraline

I. Lucki, K. Simansky, M. Kreider, 2004, Psychopharmacology.

Alterations in monoamine-containing neuronal function due to administration of antidepressants repeatedly to rats.

I. Lucki, A. Frazer, M. Sills, 2009, Acta pharmacologica et toxicologica.

Development of selective tolerance to the serotonin behavioral syndrome and suppression of locomotor activity after repeated administration of either 5-MeODMT or mCPP.

I. Lucki, A. Frazer, M. Sills, 1985, Life sciences.

Control rate of response or reinforcement and amphetamine's effect on behavior.

I. Lucki, R. E. Delong, 1983, Journal of the experimental analysis of behavior.

Effects of Serotonin-Related Gene Deletion on Measures of Anxiety, Depression, and Neurotransmission

I. Lucki, Anita J. Bechtholt, 2006 .

Buprenorphine as a Treatment for Major Depression and Opioid Use Disorder

I. Lucki, C. Browne, Amanda B. Namchuk, 2022, Advances in Drug and Alcohol Research.

Corticotropin-releasing factor in the dorsal raphe nucleus regulates activity of lateral septal neurons

I. Lucki, R. Valentino, E. Thomas, 2003, Brain Research.

NIDDK International Conference Report on Diabetes and Depression: Current Understanding and Future Directions

Norman Sartorius, Christine M. Hunter, I. Lucki, 2014, Diabetes Care.

The acute effects of antidepressant drugs on the performance of conditioned avoidance behavior in rats

I. Lucki, M. Nobler, 1985, Pharmacology Biochemistry and Behavior.

Strain differences in the effects of chronic corticosterone exposure in the hippocampus

I. Lucki, G. Hodes, S. Teegarden, 2012, Neuroscience.

Evidence for corticotropin-releasing factor regulation of serotonin in the lateral septum during acute swim stress: adaptation produced by repeated swimming

I. Lucki, R. Valentino, L. Kirby, 2002, Psychopharmacology.

Serotonin receptor specificity in anxiety disorders.

I. Lucki, 1996, The Journal of clinical psychiatry.

Overlapping and Distinct Brain Regions Associated with the Anxiolytic Effects of Chlordiazepoxide and Chronic Fluoxetine

I. Lucki, R. Valentino, Anita J. Bechtholt, 2008, Neuropsychopharmacology.

SSRIs do not cause affective blunting in healthy elderly volunteers.

I. Lucki, T. T. Have, M. Kallan, 2004, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Enhanced Sensitivity of the MRL/MpJ Mouse to the Neuroplastic and Behavioral Effects of Chronic Antidepressant Treatments

I. Lucki, D. Balu, G. Hodes, 2008, Neuropsychopharmacology.

Antidepressant-Like Effects of κ-Opioid Receptor Antagonists in Wistar Kyoto Rats

I. Lucki, R. Valentino, D. Bangasser, 2010, Neuropsychopharmacology.

Corticosterone exposure augments sensitivity to the behavioral and neuroplastic effects of fluoxetine in C57BL/6 mice

I. Lucki, Shivon A Robinson, B. Brookshire, 2016, Neurobiology of Stress.

Electrophysiological and behavioral responses to ketamine in mice with reduced Akt1 expression

I. Lucki, S. Siegel, R. Featherstone, 2013, Psychopharmacology.

Buprenorphine prevents stress-induced blunting of nucleus accumbens dopamine response and approach behavior to food reward in mice

I. Lucki, Shivon A Robinson, T. Hill-Smith, 2019, Neurobiology of Stress.

Effects of buprenorphine on behavioral tests for antidepressant and anxiolytic drugs in mice

I. Lucki, Kaitlyn L. Maier, Shivon A Robinson, 2015, Psychopharmacology.

Effects of cocaine on extracellular dopamine and serotonin levels in the nucleus accumbens

Christine M Andrews, I. Lucki, 2001, Psychopharmacology.

Abnormal salivary cortisol levels in social phobic patients in response to acute psychological but not physical stress

I. Lucki, K. Rickels, P. Furlan, 2001, Biological Psychiatry.

Regulation of Serotonin Release in the Lateral Septum and Striatum by Corticotropin-Releasing Factor

I. Lucki, M. L. Price, 2001, The Journal of Neuroscience.

Differential regulation of dopamine D2 and D3 receptors by chronic drug treatments.

I. Lucki, P. Mcgonigle, G. Stanwood, 2000, The Journal of pharmacology and experimental therapeutics.

cAMP Response Element-Binding Protein Deficiency Allows for Increased Neurogenesis and a Rapid Onset of Antidepressant Response

I. Lucki, J. Blendy, J. Malberg, 2007, The Journal of Neuroscience.

Brain Serotonin2 and Serotonin1A Receptors Are Altered in the Congenitally Hyperammonemic Sparse Fur Mouse

I. Lucki, J. Coyle, M. Robinson, 1992, Journal of neurochemistry.

Quantitative autoradiographic mapping of rat brain dopamine D3 binding with [(125)I]7-OH-PIPAT: evidence for the presence of D3 receptors on dopaminergic and nondopaminergic cell bodies and terminals.

I. Lucki, H. Kung, M. Kung, 2000, The Journal of pharmacology and experimental therapeutics.

D-serine deficiency attenuates the behavioral and cellular effects induced by the hallucinogenic 5-HT2A receptor agonist DOI

I. Lucki, J. Coyle, D. Balu, 2014, Behavioural Brain Research.

The role of the aural head shake reflex in serotonin-mediated head shaking behavior

I. Lucki, K. Eberle, N. Minugh‐Purvis, 2004, Psychopharmacology.

A role for the subthalamic nucleus in 5-HT2C-induced oral dyskinesia

I. Lucki, M. Chesselet, K. Eberle-Wang, 1996, Neuroscience.

Time‐dependent changes in sensitivity to apomorphine and monoamine receptors following withdrawal from continuous cocaine administration in rats

I. Lucki, P. Mcgonigle, J. Neisewander, 1994, Synapse.

Sex differences in the modulation of mouse nest building behavior by kappa opioid receptor signaling

I. Lucki, Moriah L. Jacobson, Mumeko C. Tsuda, 2020, Neuropharmacology.

Anatomical differentiation within the nucleus accumbens of the locomotor stimulatory actions of selective dopamine agonists andd-amphetamine

I. Lucki, W. Essman, P. Mcgonigle, 2005, Psychopharmacology.

Behavioral / Systems / Cognitive cAMP Response Element-Binding Protein Deficiency Allows for Increased Neurogenesis and a Rapid Onset of Antidepressant Response

I. Lucki, J. Blendy, J. Malberg, 2007 .

Differential craving between recovering abstinent alcoholic-dependent subjects and therapeutic users of benzodiazepines.

I. Lucki, J. Volpicelli, E. Schweizer, 1990, NIDA research monograph.

Long-term increase in sensitivity to ketamine's behavioral effects in mice exposed to mild blast induced traumatic brain injury

I. Lucki, Moriah L. Jacobson, Mario G. Oyola, 2021, Experimental Neurology.

Simultaneous analyses of the neurochemical and behavioral effects of the norepinephrine reuptake inhibitor reboxetine in a rat model of antidepressant action.

I. Lucki, M. Page, K. Brown, 2003, Psychopharmacology.

The 5-HT1A receptor modulates the effects of cocaine on extracellular serotonin and dopamine levels in the nucleus accumbens.

Christine M Andrews, I. Lucki, H. Kung, 2005, European journal of pharmacology.

Kappa Opioid Receptors in the Pathology and Treatment of Major Depressive Disorder.

I. Lucki, C. Browne, Hildegard A. Wulf, 2021, Handbook of experimental pharmacology.

Translational relevance of fear conditioning in rodent models of mild traumatic brain injury

I. Lucki, Kwang H. Choi, Claire Kostelnik, 2021, Neuroscience & Biobehavioral Reviews.

Anxiolytic effect of serotonin depletion in the novelty-induced hypophagia test

I. Lucki, Anita J. Bechtholt, Tiffany E. Hill, 2007, Psychopharmacology.

Differential regulation of central BDNF protein levels by antidepressant and non-antidepressant drug treatments

I. Lucki, D. Balu, J. Malberg, 2008, Brain Research.

Editorial: Reporting guidelines for psychopharmacology

T. Robbins, I. Lucki, D. Hoyer, 2016, Psychopharmacology.

5-HT1A receptor function in major depressive disorder

I. Lucki, W. Drevets, J. Savitz, 2009, Progress in Neurobiology.

High fat diet produces brain insulin resistance, synaptodendritic abnormalities and altered behavior in mice

I. Lucki, S. Arnold, G. Carlson, 2014, Neurobiology of Disease.

Effects of buprenorphine on behavioral tests for antidepressant and anxiolytic drugs in mice

I. Lucki, Kaitlyn L. Maier, Shivon A Robinson, 2014, Psychopharmacology.

Simultaneous analyses of the neurochemical and behavioral effects of the norepinephrine reuptake inhibitor reboxetine in a rat model of antidepressant action

I. Lucki, M. Page, K. Brown, 2002, Psychopharmacology.

Protracted Effects of Ketamine Require Immediate Kappa Opioid Receptor Activation and Long‐Lasting Desensitization

I. Lucki, Moriah L. Jacobson, Fereshteh S. Nugent, 2020, The FASEB Journal.

Psychomotor performance following the long-term use of benzodiazepines.

I. Lucki, K. Rickels, A. Geller, 1985, Psychopharmacology bulletin.

5-Hydroxytryptamine1A receptors and behavioral responses.

I. Lucki, S. Wieland, 1990, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

Chronic administration of the 5‐HT1A receptor agonist 8‐OH‐DPAT differentially desensitizes 5‐HT1A autoreceptors of the dorsal and median raphe nuclei

I. Lucki, D. S. Kreiss, Irwin Lucki, 1997, Synapse.

Depressive phenotypes evoked by experimental diabetes are reversed by insulin

I. Lucki, Monica R. F. Hilário, J. Blendy, 2012, Physiology & Behavior.

Antidepressant-like effects of the novel, selective, 5-HT2C receptor agonist WAY-163909 in rodents

I. Lucki, K. Marquis, S. Grauer, 2007, Psychopharmacology.

Simultaneous analyses of the neurochemical and behavioral effects of the norepinephrine reuptake inhibitor reboxetine in a rat model of antidepressant action

I. Lucki, M. Page, K. Brown, 2002, Psychopharmacology.